How Long Can We Give Interleukin-2? Clinical and Immunological Evaluation of AML Patients After 10 or More Years of IL2 Administration

Leukemia - United Kingdom
doi 10.1038/sj.leu.2402566
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Now We Are 40 – 10 More Years of MOGA

Asia-Pacific Journal of Clinical Oncology
MedicineOncology
2019English

Gulf War Veteran Health Care Utilization: After More Than 10 Years of Study, What Have We Learned?

2000English

How Can We Breed for More Water Use-Efficient Sugarcane?

Journal of Experimental Botany
Plant SciencePhysiology
2016English

Implant Retained or Conventional Dentures, Which Give More Patients Satisfaction?

Evidence-Based Dentistry
Dentistry
2006English

Alimentary Satisfaction, Gastrointestinal Symptoms, and Quality of Life 10 or More Years After Esophagectomy With Gastric Pull-Up

Journal of Thoracic and Cardiovascular Surgery
Respiratory MedicinePulmonaryCardiovascular MedicineSurgeryCardiology
2014English

Epidemiological and Entomological Evaluations After Six Years or More of Mass Drug Administration for Lymphatic Filariasis Elimination in Nigeria

PLoS Neglected Tropical Diseases
PharmacologyPublic HealthEnvironmentalToxicologyInfectious DiseasesPharmaceuticsOccupational Health
2011English

How Can We Make Visualization More Useful to the Working Scientist?

Computers in Physics
1995English

Which Women Breastfeed for 2 Years or More?

Jornal de Pediatria
Child HealthPediatricsPerinatology
2012English

Serum Levels of Interleukin 10 (IL-10) in Patients With Type 2 Diabetes

Clinical Biochemistry
MedicineClinical Biochemistry
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy